New Hampshire enters MOU with FDA regarding inordinate amounts of Compounded human drug products shipped interstate

 

MOU No.	Purpose	Parties	FDA Lead Center or Office/Contact	Effective Date	Expiration Date	Last Revision Date
225-21-008	This MOU establishes an agreement with the New Hampshire Office of Professional Licensure and Certification regarding the distribution of inordinate amounts of compounded human drug products interstate and the appropriate investigation by the New Hampshire Office of Professional Licensure and Certification of complaints relating to human drug products compounded in New Hampshire and distributed outside the state.	New Hampshire Office of Professional Licensure and Certification (OPLC)	CDER / Office of Compliance / Office of Compounding Quality and Compliance F. Gail Bormel, Director compounding@fda.hhs.gov